CDx news
Meet GenDx at the 16th Annual CB & CDx summit in Boston
We are excited to announce that the GenDx Companion Diagnostics team will be in Boston for the 16th World Clinical […]
Exploring HLA in tumors: The role of HLA in immune checkpoint inhibitor therapy
In previous blog posts in this series, we introduced the central role of HLA molecules in tumor immunology and discussed […]
Exploring HLA in tumors: Immune evasion through HLA modulation in cancer
As introduced in the previous blog post in this series, HLA molecules are central to the presentation of tumor antigens […]
Exploring HLA in tumors: Introduction to HLA in healthy tissue and the tumor microenvironment
HLA plays an important role in the immune system and is more and more leveraged in HLA-restricted precision medicine therapies, […]
NGS vs Sanger-based HLA typing for Companion Diagnostics: key differences and clinical implications
While still emerging in clinical practice, HLA-restricted therapies are gaining traction in clinical research and early-stage precision medicine applications (see […]
The role of HLA in immunotherapy development
Human Leukocyte Antigen (HLA) proteins have long been central in the transplantation field, because of their critical role on transplant […]
